Clinical Trial Update: Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.

View source ↗

Summary

A retrospective Danish cohort study (DARENCA Study 2) analyzes progression-free survival and overall survival in patients with metastatic renal cell carcinoma t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Pfizer | Conditions: Renal Cell Carcinoma | Status: COMPLETED